These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20104071)

  • 61. No evidence for an anti-inflammatory effect of escitalopram intervention in healthy individuals with a family history of depression.
    Haastrup E; Knorr U; Erikstrup C; Kessing LV; Ullum H
    J Neuroimmunol; 2012 Feb; 243(1-2):69-72. PubMed ID: 22244574
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Psychological distress in informal caregivers of patients with dementia in primary care: course and determinants.
    Borsje P; Hems MA; Lucassen PL; Bor H; Koopmans RT; Pot AM
    Fam Pract; 2016 Aug; 33(4):374-81. PubMed ID: 26969508
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study.
    Quante A; Regen F; Schindler F; Volkmer K; Severus E; Urbanek C; Luborzewski A; Roepke S; Anghelescu I
    Psychiatr Danub; 2013 Sep; 25(3):214-20. PubMed ID: 24048387
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combined treatment with escitalopram and memantine increases gray matter volume and cortical thickness compared to escitalopram and placebo in a pilot study of geriatric depression.
    Krause-Sorio B; Siddarth P; Kilpatrick L; Laird KT; Milillo MM; Ercoli L; Narr KL; Lavretsky H
    J Affect Disord; 2020 Sep; 274():464-470. PubMed ID: 32663977
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
    Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
    Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Placebo response and antidepressant response.
    Alexopoulos GS; Kanellopoulos D; Murphy C; Gunning-Dixon F; Katz R; Heo M
    Am J Geriatr Psychiatry; 2007 Feb; 15(2):149-58. PubMed ID: 17272735
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Baseline severity of depression predicts antidepressant drug response relative to escitalopram.
    Kilts CD; Wade AG; Andersen HF; Schlaepfer TE
    Expert Opin Pharmacother; 2009 Apr; 10(6):927-36. PubMed ID: 19317630
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial.
    Muller JE; Wentzel I; Koen L; Niehaus DJ; Seedat S; Stein DJ
    Int Clin Psychopharmacol; 2008 Jan; 23(1):43-8. PubMed ID: 18090507
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD).
    Hansen BH; Hanash JA; Rasmussen A; Hansen JF; Birket-Smith M
    Trials; 2009 Apr; 10():20. PubMed ID: 19351383
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antidepressant therapy in patients undergoing coronary artery bypass grafting: the MOTIV-CABG trial.
    Chocron S; Vandel P; Durst C; Laluc F; Kaili D; Chocron M; Etievent JP
    Ann Thorac Surg; 2013 May; 95(5):1609-18. PubMed ID: 23566649
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevention of poststroke apathy using escitalopram or problem-solving therapy.
    Mikami K; Jorge RE; Moser DJ; Arndt S; Jang M; Solodkin A; Small SL; Fonzetti P; Hegel MT; Robinson RG
    Am J Geriatr Psychiatry; 2013 Sep; 21(9):855-62. PubMed ID: 23930743
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Life enhancing activities for family caregivers of people with frontotemporal dementia.
    Dowling GA; Merrilees J; Mastick J; Chang VY; Hubbard E; Moskowitz JT
    Alzheimer Dis Assoc Disord; 2014; 28(2):175-81. PubMed ID: 24113564
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity.
    Lavretsky H; Epel ES; Siddarth P; Nazarian N; Cyr NS; Khalsa DS; Lin J; Blackburn E; Irwin MR
    Int J Geriatr Psychiatry; 2013 Jan; 28(1):57-65. PubMed ID: 22407663
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Escitalopram is associated with reductions in pain severity and pain interference in opioid dependent patients with depressive symptoms.
    Tsui JI; Herman DS; Kettavong M; Anderson BJ; Stein MD
    Pain; 2011 Nov; 152(11):2640-2644. PubMed ID: 21924552
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neuroplasticity-based computerized cognitive remediation for treatment-resistant geriatric depression.
    Morimoto SS; Wexler BE; Liu J; Hu W; Seirup J; Alexopoulos GS
    Nat Commun; 2014 Aug; 5():4579. PubMed ID: 25093396
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transcriptomic signatures of treatment response to the combination of escitalopram and memantine or placebo in late-life depression.
    Grzenda A; Siddarth P; Laird KT; Yeargin J; Lavretsky H
    Mol Psychiatry; 2021 Sep; 26(9):5171-5179. PubMed ID: 32382137
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differences in depression severity in family caregivers of hospitalized individuals with dementia and family caregivers of outpatients with dementia.
    Epstein-Lubow G; Gaudiano B; Darling E; Hinckley M; Tremont G; Kohn R; Marino LJ; Salloway S; Grinnell R; Miller IW
    Am J Geriatr Psychiatry; 2012 Sep; 20(9):815-9. PubMed ID: 21997604
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Improvement in Quality of Life of Postmenopausal Women with Depression with commonly used Antidepressants (Escitalopram vs. Desvenlafaxine): A Randomized Controlled Trial in a Tertiary Care Teaching Hospital of North India.
    Mahajan SS; Arora M; Tandon VR; Mahajan A; Kotwal S
    J Midlife Health; 2022; 13(1):80-84. PubMed ID: 35707303
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Designing a need-based program for relieving psychological distress of family caregivers of leukemia patients: a randomized controlled trial.
    Abdullahzadeh M; Khosravi N
    Support Care Cancer; 2021 Dec; 29(12):7601-7610. PubMed ID: 34131846
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of escitalopram on vagally mediated cardiovascular function in healthy participants: implications for understanding differential age-related, treatment emergent effects.
    Kemp AH; Outhred T; Saunders S; Brunoni AR; Nathan PJ; Malhi GS
    Psychopharmacology (Berl); 2014 Jun; 231(11):2281-90. PubMed ID: 24337078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.